Intensity Therapeutics Inc. (INTS)
NASDAQ · Healthcare
Intensity Therapeutics Inc. Revenue 2020–2025
Intensity Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Intensity Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0.
- Intensity Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Intensity Therapeutics Inc. annual revenue for 2025 was 0.
- Intensity Therapeutics Inc. annual revenue for 2024 was 0.
- Intensity Therapeutics Inc. annual revenue for 2023 was 0.
- Intensity Therapeutics Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Intensity Therapeutics Inc. (INTS) — Frequently Asked Questions
Intensity Therapeutics Inc. (INTS) is a publicly traded US company. It has a market capitalization of $5M. Explore INTS's stock price, financial statements, earnings history, margins and key ratios below.
What is Intensity Therapeutics Inc.'s market cap?
Intensity Therapeutics Inc. (INTS) has a market capitalization of $5M.
What is the INTS stock price?
INTS trades at $3.74 (+0.81% on the day).
Is INTS profitable?
In fiscal 2025, Intensity Therapeutics Inc. reported net income of -$12M.